ClearBridge Investments’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-814,934
Closed -$18.7M 735
2025
Q1
$18.7M Buy
814,934
+46,762
+6% +$1.13M 0.02% 415
2024
Q4
$19.5M Sell
768,172
-123,968
-14% -$3.14M 0.02% 440
2024
Q3
$22.2M Sell
892,140
-1,092,523
-55% -$32.4M 0.02% 438
2024
Q2
$58.8M Sell
1,984,663
-30,851
-2% -$856K 0.05% 297
2024
Q1
$60.8M Buy
2,015,514
+109,561
+6% +$3.04M 0.05% 305
2023
Q4
$54.5M Sell
1,905,953
-239,715
-11% -$7.04M 0.05% 319
2023
Q3
$79.5M Sell
2,145,668
-34,367
-2% -$1.31M 0.08% 247
2023
Q2
$85M Sell
2,180,035
-203,344
-9% -$7.97M 0.08% 249
2023
Q1
$87M Buy
2,383,379
+38,911
+2% +$1.23M 0.08% 230
2022
Q4
$72.2M Buy
+2,344,468
New +$72.8M 0.07% 259

Other funds holding RTO

ClearBridge Investments's RTO Position: Q2 2025 in Review

ClearBridge Investments sold out of Rentokil (RTO) in Q2 2025, closing a stake of 814,934 shares — an estimated $18.7M sold.

ClearBridge Investments first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $87M in Q1 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • ClearBridge Investments reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • ClearBridge Investments sold 814,934 Rentokil shares in Q2 2025, an estimated $18.7M.
  • ClearBridge Investments first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • ClearBridge Investments's Rentokil position peaked at $87M in Q1 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on ClearBridge Investments's 13F filing for Q2 2025, filed 12 Aug 2025.